MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd. (MDCX) is expected to report earnings on November 11, 2026, after the market close. The consensus earnings estimate is a loss of $0.11 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -15.6% since its last earnings release on August 12, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Medicus Pharma Ltd.
Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.
Sector
Healthcare
Industry
Biotechnology